Predictive Oncology Inc. [NASDAQ: POAI] loss -4.97% on the last trading session, reaching $0.94 price per share at the time.
Predictive Oncology Inc. represents 15.42 million in outstanding shares, while the company has a total market value of $14.94 million with the latest information. POAI stock price has been found in the range of $0.83 to $1.04.
If compared to the average trading volume of 1.41M shares, POAI reached a trading volume of 4365078 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Predictive Oncology Inc. [POAI]:
The Average True Range (ATR) for Predictive Oncology Inc. is set at 0.10, with the Price to Sales ratio for POAI stock in the period of the last 12 months amounting to 11.49. The Price to Book ratio for the last quarter was 0.79, with the Price to Cash per share for the same quarter was set at 0.21.
Trading performance analysis for POAI stock
Predictive Oncology Inc. [POAI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.16. With this latest performance, POAI shares dropped by -20.54% in over the last four-week period, additionally sinking by -36.22% over the last 6 months – not to mention a drop of -81.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for POAI stock in for the last two-week period is set at 41.33, with the RSI for the last a single of trading hit 49.45, and the three-weeks RSI is set at 39.30 for Predictive Oncology Inc. [POAI]. The present Moving Average for the last 50 days of trading for this stock 1.2687, while it was recorded at 0.8970 for the last single week of trading, and 1.8084 for the last 200 days.
Predictive Oncology Inc. [POAI]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Predictive Oncology Inc. [POAI] shares currently have an operating margin of -975.83 and a Gross Margin at +12.39. Predictive Oncology Inc.’s Net Margin is presently recorded at -1373.71.
Return on Total Capital for POAI is now -149.36, given the latest momentum, and Return on Invested Capital for the company is -335.62. Return on Equity for this stock declined to -343.66, with Return on Assets sitting at -148.68. When it comes to the capital structure of this company, Predictive Oncology Inc. [POAI] has a Total Debt to Total Equity ratio set at 49.20. Additionally, POAI Total Debt to Total Capital is recorded at 32.97, with Total Debt to Total Assets ending up at 24.69. Long-Term Debt to Equity for the company is recorded at 2.41, with the Long-Term Debt to Total Capital now at 1.61.
Reflecting on the efficiency of the workforce at the company, Predictive Oncology Inc. [POAI] managed to generate an average of -$605,961 per employee. Receivables Turnover for the company is 2.75 with a Total Asset Turnover recorded at a value of 0.11.Predictive Oncology Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.30.
An analysis of insider ownership at Predictive Oncology Inc. [POAI]
There are presently around $1 million, or 7.10% of POAI stock, in the hands of institutional investors. The top three institutional holders of POAI stocks are: ARMISTICE CAPITAL, LLC with ownership of 484,624, which is approximately 86.394% of the company’s market cap and around 11.60% of the total institutional ownership; SABBY MANAGEMENT, LLC, holding 223,540 shares of the stock with an approximate value of $0.21 million in POAI stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $0.17 million in POAI stock with ownership of nearly New of the company’s market capitalization.
13 institutional holders increased their position in Predictive Oncology Inc. [NASDAQ:POAI] by around 761,737 shares. Additionally, 3 investors decreased positions by around 2,755 shares, while 4 investors held positions by with 301,343 shares. The mentioned changes placed institutional holdings at 1,065,835 shares, according to the latest SEC report filing. POAI stock had 10 new institutional investments in for a total of 493,047 shares, while 2 institutional investors sold positions of 926 shares during the same period.